<DOC>
	<DOC>NCT00451750</DOC>
	<brief_summary>The aim of this prospective, double-blind, placebo-controlled, randomized study is to investigate if glucocorticoid treatment, in combination with exposure therapy, helps to reduce phobic fear in patients with phobia.</brief_summary>
	<brief_title>Cortisol in the Treatment of Phobias</brief_title>
	<detailed_description />
	<mesh_term>Phobic Disorders</mesh_term>
	<mesh_term>Hydrocortisone 17-butyrate 21-propionate</mesh_term>
	<mesh_term>Cortisol succinate</mesh_term>
	<mesh_term>Hydrocortisone acetate</mesh_term>
	<mesh_term>Hydrocortisone</mesh_term>
	<criteria>Female and male patients with a specific phobia (fear of heights) according to DSMIV criteria. Severe acute or chronic somatic diseases Psychiatric disorder other than specific phobia Topic glucocorticoid therapy (for large skin parts) Inhaled glucocorticoids Psychotropic medication Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>January 2010</verification_date>
	<keyword>phobia</keyword>
	<keyword>cortisol</keyword>
	<keyword>memory</keyword>
	<keyword>treatment</keyword>
</DOC>